TransMedics (TMDX) Interest Coverage Ratio Growth (1y) (2019 - 2026)
TransMedics (TMDX) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.91% |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | -68.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -78.44% |
| Mar 31, 2026 | -99.55% |
| Dec 31, 2025 | 126.22% |
| Sep 30, 2025 | 515.37% |
| Jun 30, 2025 | 204.71% |
| Mar 31, 2025 | 129.69% |
| Dec 31, 2024 | -2,140.04% |
| Sep 30, 2024 | 113.74% |
| Jun 30, 2024 | 1,054.55% |
| Mar 31, 2024 | 281.78% |
| Dec 31, 2023 | 105.53% |
| Sep 30, 2023 | -12.04% |
| Jun 30, 2023 | 96.39% |
| Mar 31, 2023 | 80.54% |
| Dec 31, 2022 | 73.97% |
| Sep 30, 2022 | -19.98% |
| Jun 30, 2022 | -107.97% |
| Mar 31, 2022 | -214.66% |
| Dec 31, 2021 | -325.93% |
| Sep 30, 2021 | -148.10% |